INMB
INmune Bio Inc
NASDAQ: INMB · HEALTHCARE · BIOTECHNOLOGY
$1.33
-5.00% today
Updated 2026-04-29
Market cap
$39.08M
P/E ratio
—
P/S ratio
781.61x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$1 – $8
Volume
0.4M
INmune Bio Inc (INMB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |